Subcutaneous methotrexate in patients with moderate-to-severe psoriasis: a critical appraisal. (2018)

First Author: Tsakok T
Attributed to:  Clinical, genetic and immune determinants of drug immunogenicity in psoriasis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjd.16424

PubMed Identifier: 29399784

Publication URI: http://europepmc.org/abstract/MED/29399784

Type: Journal Article/Review

Volume: 179

Parent Publication: The British journal of dermatology

Issue: 1

ISSN: 0007-0963